Sleep & Recovery
SS-31 (Elamipretide)
Mitochondrial-targeted peptide for cellular energy and recovery
Dosage
5-20mg daily
Results
2-4 weeks
Frequency
Daily
Cost
$200-400/month
Estimated monthly
$200-400
About SS-31 (Elamipretide)
SS-31 (Elamipretide) is a mitochondria-targeted peptide that binds to cardiolipin, a lipid essential for mitochondrial function. It helps stabilize the inner mitochondrial membrane, improving energy production and reducing oxidative stress. Originally developed for heart failure, it's being studied for age-related mitochondrial dysfunction.
Administration
Method
Subcutaneous injection
Timing
AM
Food
Any time
Key Benefits
- Targets mitochondrial cardiolipin
- Improves cellular energy
- Enhances exercise capacity
- Supports heart function
- Reduces oxidative stress
Stacks Well With
Important Considerations
- • Pregnancy
Additional Notes
- • Cutting-edge mitochondrial support
- • Research peptide
Research & Studies
SS-31: Cardiolipin-Targeted Mitochondrial Therapy
2014·PubMed
Elamipretide: Heart Failure Clinical Trials
2019·Clinical Trial
Research provided for educational purposes. Always consult a healthcare provider.